These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 25727451)

  • 21. A Risk Assessment Matrix for Public Health Principles: The Case for E-Cigarettes.
    Saitta D; Chowdhury A; Ferro GA; Nalis FG; Polosa R
    Int J Environ Res Public Health; 2017 Mar; 14(4):. PubMed ID: 28362360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Policy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk.
    Givel M
    Curr Drug Abuse Rev; 2008 Jun; 1(2):135-41. PubMed ID: 19630712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Origins of tobacco harm reduction in the UK: the 'Product Modification Programme' (1972-1991).
    Elias J; Ling PM
    Tob Control; 2018 Jul; 27(e1):e12-e18. PubMed ID: 29330172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electronic cigarettes. A position statement of the forum of international respiratory societies.
    Schraufnagel DE; Blasi F; Drummond MB; Lam DC; Latif E; Rosen MJ; Sansores R; Van Zyl-Smit R;
    Am J Respir Crit Care Med; 2014 Sep; 190(6):611-8. PubMed ID: 25006874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement.
    Leone FT; Carlsen KH; Chooljian D; Crotty Alexander LE; Detterbeck FC; Eakin MN; Evers-Casey S; Farber HJ; Folan P; Kathuria H; Latzka K; McDermott S; McGrath-Morrow S; Moazed F; Munzer A; Neptune E; Pakhale S; Sachs DPL; Samet J; Sufian B; Upson D
    Am J Respir Crit Care Med; 2018 Oct; 198(8):e90-e105. PubMed ID: 30320525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electronic nicotine delivery systems: executive summary of a policy position paper from the American College of Physicians.
    Crowley RA;
    Ann Intern Med; 2015 Apr; 162(8):583-4. PubMed ID: 25894027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobacco harm reduction: how rational public policy could transform a pandemic.
    Sweanor D; Alcabes P; Drucker E
    Int J Drug Policy; 2007 Mar; 18(2):70-4. PubMed ID: 17689347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forensic analysis of online marketing for electronic nicotine delivery systems.
    Cobb NK; Brookover J; Cobb CO
    Tob Control; 2015 Mar; 24(2):128-31. PubMed ID: 24038037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tobacco harm reduction: promise and perils.
    Warner KE
    Nicotine Tob Res; 2002; 4 Suppl 2():S61-71. PubMed ID: 12580158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The US tobacco control community's view of the future of tobacco harm reduction.
    Warner KE; Martin EG
    Tob Control; 2003 Dec; 12(4):383-90. PubMed ID: 14660773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should the health community promote smokeless tobacco (snus) as a harm reduction measure?
    Gartner CE; Hall WD; Chapman S; Freeman B
    PLoS Med; 2007 Jul; 4(7):e185. PubMed ID: 17608560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory issues concerning the development and circulation of nicotine-containing products: a qualitative study.
    Rooke C; McNeill A; Arnott D
    Nicotine Tob Res; 2013 Jun; 15(6):1052-9. PubMed ID: 23128517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A call for an urgent ban on E-cigarettes in India--a race against time.
    Kaur J; Rinkoo AV
    Glob Health Promot; 2015 Jun; 22(2):71-4. PubMed ID: 24938513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tobacco control in Namibia: the importance of government capacity, media coverage and industry interference.
    Tam J; van Walbeek C
    Tob Control; 2014 Nov; 23(6):518-23. PubMed ID: 23788605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there any legal and scientific basis for classifying electronic cigarettes as medications?
    Farsalinos KE; Stimson GV
    Int J Drug Policy; 2014 May; 25(3):340-5. PubMed ID: 24709413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harm reduction in tobacco control: where do we draw the line?
    Al-Hamdani M; Manly E
    J Public Health Policy; 2022 Mar; 43(1):149-154. PubMed ID: 34997211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public policy to maximize tobacco cessation.
    McGoldrick DE; Boonn AV
    Am J Prev Med; 2010 Mar; 38(3 Suppl):S327-32. PubMed ID: 20176304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimising the harm from nicotine use: finding the right regulatory framework.
    Borland R
    Tob Control; 2013 May; 22 Suppl 1(Suppl 1):i6-9. PubMed ID: 23591515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.